VTE

FDA Accepted to Review Bristol-Myers and Pfizer's Eliquis Supplemental New Drug
Jul 12, 2013
The US FDA has accepted to review Bristol-Myers Squibb Company and Pfizer's Eliquis (apixaban) supplemental new drug application for prophylaxis of deep vein thrombosis (DVT) subsequent to hip or knee replacement surgery. The application ...

Tags: Drug Application, Medicine
Janssen Research & Development Has Submitted Supplemental New Drug Applications
Dec 5, 2012
Janssen Research & Development has submitted supplemental New Drug Applications (sNDAs) to the US Food and Drug Administration (FDA) for the use of Xarelto (rivaroxaban), an oral anticoagulant. Janssen said the drug is used to treat ...

Tags: Xarelto, rivaroxaban, DVT, pulmonary embolism, VTE
Bayer HealthCare Pharmaceuticals Has Updated The Labels
Dec 5, 2012
Bayer HealthCare Pharmaceuticals has updated the labels for its drospirenone-containing combination oral contraceptives (COCs) in the US. The revised labels state that COCs containing drospirenone may be associated with a higher risk of ...

Tags: COCs containing drospirenone, VTE, venous thromboembolism